Skip to main content
Ivana Kim, MD, Ophthalmology, Boston, MA, Massachusetts Eye and Ear

IvanaK.KimMD

Ophthalmology Boston, MA

Associate Professor, Ophthalmology, Harvard Medical School

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kim's full profile

Already have an account?

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2001
  • Harvard Medical School
    Harvard Medical SchoolClass of 1997

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2026
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Survival Rates in Patients After Treatment for Metastasis from Uveal Melanoma  
    Ivana K Kim, Evangelos S Gragoudas, JAMA

Press Mentions

  • Clearside Biomedical Announces Positive Data on CLS-AX OASIS Clinical Trial and Use of SCS Microinjector
    Clearside Biomedical Announces Positive Data on CLS-AX OASIS Clinical Trial and Use of SCS MicroinjectorFebruary 21st, 2023
  • Aura Biosciences Announces Positive Interim Phase 2 Data of Belzupacap Sarotalocan for Treatment of Early-Stage Choroidal Melanoma
    Aura Biosciences Announces Positive Interim Phase 2 Data of Belzupacap Sarotalocan for Treatment of Early-Stage Choroidal MelanomaFebruary 16th, 2023
  • Aura Biosciences to Present Updated Belzupacap Sarotalocan (AU-011) Data on Multiple Studies at the International Society of Ocular Oncology 2022 Bi-Annual Meeting
    Aura Biosciences to Present Updated Belzupacap Sarotalocan (AU-011) Data on Multiple Studies at the International Society of Ocular Oncology 2022 Bi-Annual MeetingJune 19th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations